There also appears to be an interplay between the Th17/IL-17 axis and vasculopathy in humans: murine models demonstrate aneurysm formation from IL-17A blockade [85], while blocking HIF-1α causes coronary vessel abnormalities and prevents Th17 lymphocyte differentiation [87]. The gene discussed is IL17A; the disease is aneurysm.